<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>pathological complete response predicts rectal cancer outcome — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>pathological complete response</strong>
  <span class="pred">&mdash;predicts&rarr;</span>
  <strong>rectal cancer outcome</strong>
</div>
<div class="entity-id">UNKNOWN:pathological complete response &nbsp;&middot;&nbsp; MESH:D012004</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 67.30<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.3390/ijms18030573">10.3390/ijms18030573</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 17 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>9</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">pre-therapeutic serum metabolites — predicts → nCRT-induced diarrhea</span><a href="../claim/750712ea3aa72b8c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">pre-therapeutic serum metabolites — predicts → nCRT-induced hematologic toxicity</span><a href="../claim/86a5fd182917ba6f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acyl carnitines — correlates_with → sex disparity in nCRT-induced diarrhea</span><a href="../claim/b0934b7e792b3dc7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">neoadjuvant chemoradiotherapy (nCRT) — causes → serum metabolic alterations</span><a href="../claim/6da331b88e6eff21.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — is_biomarker_for → colorectal adenocarcinoma</span><a href="../claim/e0e672f7538caff6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">long-chain and very-long-chain fatty acids — increases → colorectal adenocarcinoma</span><a href="../claim/cbb3f19d3e71e361.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">de novo lipogenesis — increases → colorectal cancer</span><a href="../claim/52f46dfa92385363.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — decreases → lymphovascular invasion in colorectal cancer</span><a href="../claim/5b8f3f1ed7054976.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — is_biomarker_for → lymphovascular invasion-negative colorectal cancer</span><a href="../claim/942179be032f2958.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:56px"></span><span>5</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine metabolism — predicts → nCRT therapeutic response in rectal cancer</span><a href="../claim/37cf9aa341c8f61b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">essential amino acid metabolism — predicts → nCRT therapeutic response in rectal cancer</span><a href="../claim/810a7e4299423912.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomic profile — predicts → response to neoadjuvant therapy</span><a href="../claim/e10cd54cfa1d5466.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomic analysis — correlates_with → poor progression-free survival</span><a href="../claim/e781d9930061b82d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolic biomarkers — predicts → rectal cancer diagnosis</span><a href="../claim/863c6624787566e1.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:33px"></span><span>3</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">DESI-MSI spectral profiles — distinguishes → colorectal adenocarcinoma</span><a href="../claim/7fb33aa3d4f25910.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidized phospholipids — distinguishes → lymphovascular invasion status in colorectal cancer</span><a href="../claim/235bd2fc243a7d41.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolic biomarkers — is_biomarker_for → colorectal cancer</span><a href="../claim/9928a30485db1e0a.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>4979fa441f6dcc5e</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:pathological complete response">UNKNOWN:pathological complete response</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D012004">MESH:D012004</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
